Can abuse deterrent formulations make a difference? Expectation and speculation

Harm Reduction Journal

Volumn 6, Issue , 2009, Pages

  Budman, Simon H ^a   Grimes Serrano, Jill M ^a   Butler, Stephen F ^a  

^a INFLEXXION INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; FENTANYL; HYDROCODONE BITARTRATE PLUS PARACETAMOL; MORPHINE; MORPHINE SULFATE; OPIATE; OXYCODONE; SEDATIVE AGENT;

ABUSE DETERRENT FORMULATION; ARTICLE; DRUG ABUSE PATTERN; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG MISUSE; HIGH RISK BEHAVIOR; HUMAN; INFECTION RISK; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OPIATE ADDICTION; PAIN; PRESCRIPTION; RISK FACTOR; SEXUAL BEHAVIOR; SOCIAL ENVIRONMENT; SOCIAL PROBLEM; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 67650069173     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-6-8     Document Type: Article

References (45)

1. Trescot AM Boswell MV Atluri SL Hansen HC Deer TR Abdi S Jasper JF Singh V Jordan AE Johnson BW et al Opioid guidelines in the management of chronic non-cancer pain Pain Physician 2006, 9:1-39. 16700278
2. Brennan F Carr DB Cousins M Pain management: A fundamental human right Anesth Analg 2007, 105:205-221. 10.1213/01.ane.0000268145.52345.55 17578977
3. SAMSHA 2006 National Survey on Drug Use & Health: National Results Rockville, MD: Substance Abuse Mental Health Services Administration 2007.
4. White AG Birnbaum HG Mareva MN Daher M Vallow S Shein J Katz N Direct costs of opioid abuse in an insured population in the United States J Manag Care Pharm 2005, 11:469-479. 15998164
5. Katz NP Adams EH Benneyan JC Birnbaum HG Budman SH Buzzeo RW Carr DB Cicero TJ Gourlay D Inciardi JA et al Foundations of opioid risk management Clin J Pain 2007, 23:103-118. 10.1097/ 01.ajp.0000210953.86255.8f 17237659
6. Katz N Abuse-deterrent opioid formulations: Are they a pipe dream? Curr Rheumatol Rep 2008, 10:11-18. 10.1007/s11926-008-0003-z 18457606
7. Sunshine Analgesic Efficacy of Pentazocine Versus a Pentazocine-Naloxone Combination Following Oral Administration Clinical Journal of Pain 1988, 4:35-40.
8. Farre M Cami J Pharmacokinetic considerations in abuse liability evaluation Br J Addict 1991, 86:1601-1606. 10.1111/ j.1360-0443.1991.tb01754.x 1786493
9. Oldendorf WH Some relationships between addiction and drug delivery to the brain Bioavailabilty of drugs to the brain and the blood-brain barrier Rockville, MD: National Institute on Drug Abuse Frankenheim J, Brown RM 1992, 120.
10. Jenkins AJ Keenan RM Henningfield JE Cone EJ Pharmacokinetics and pharmacodynamics of smoked heroin J Anal Toxicol 1994, 18:317-330. 7823539
11. Mansbach RS Moore RA Jr Formulation considerations for the development of medications with abuse potential Drug Alcohol Depend 2006, 83(Suppl 1):S15-22. 10.1016/j.drugalcdep.2005.10.018 16472940
12. Balster RL Schuster CR Fixed interval schedule of cocaine reinforcement: effect of dose and infusion duration Journal of Experimental and Analytical Behavior 1973, 20:119-129. 10.1901/jeab.1973.20-119
13. Wakasa Y Takada K Yanagita T Reinforcing effect as a function of infusion speed intravenous self-adminsitration of nicotine in rhesus monkeys Nihon Shinkei Seishin Yakurigaku Zasshi. 1995, 15(1):53-59. 7750017
14. deWit H Bodker B Ambre J Rate of increase of plasma drug level influences subjective response in humans Psychopharmacology 1992, 107:352-358. 10.1007/BF02245161 1615136
15. deWit H Dudish S Ambre J Subjective and behavioral effects of diazepam depend on its rate of onset Psychopharmacology 1993, 112:324-330. 10.1007/BF02244928 7871037
16. Marsch LA Bickel WK Badger GJ Rathmell JP Swedberg MD Jonzon B Norsten-Hoog C Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans J Pharmacol Exp Ther 2001, 299:1056-1065. 11714895
17. Roset PN Farre M de la Torre R Mas M Menoyo E Hernandez C Cami J Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males Drug Alcohol Depend 2001, 64:285-298. 10.1016/ S0376-8716(01)00127-2 11672943
18. Butler SF Benoit C Budman SH Fernandez KC McCormick C Venuti SW Katz N Development and validation of an Opioid Attractiveness Scale: A novel measure of the attractiveness of opioid products to potential abusers Harm Reduct J 2006, 3:5. 1382206 16457713 10.1186/1477-7517-3-5
19. Butler SF Budman SH Licari A Cassidy TA Lioy K Dickinson J Brownstein JS Benneyan JC Green TC Katz N National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO™): A real-time, product-specific, public health surveillance system for monitoring prescription drug abuse Pharmacoepidemiology and Drug Safety 2008, 17:1142-1154. 10.1002/pds.1659
20. Green TC Butler SF A latent class analysis of prescription opioid abuse in the National Addictions Vigilance Intervention & Prevention Program (NAVIPPROTM) College on Drug Dependence San Juan, Puerto Rico 2008.
21. Butler SF Budman SH Natural History of Prescription Opioid Addition: Time Using Opioids, Patterns of Use, and Problem Severity in Clients in Treatment College on Drug Dependence San Juan, Puerto Rico 2008.
22. O'Dowd Sexual risk status and behavior of New Jersey adults: Results form the New Jersey behavioral risk study, 1998-1999 New Jersey Department of Health and Senior Services 2003.
23. Neaigus A Gyarmathy VA Miller M Frajzyngier VM Friedman SR Des Jarlais DC Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility J Acquir Immune Defic Syndr 2006, 41:493-503. 10.1097/01.qai.0000186391.49205.3b 16652059
24. Harocopos A Goldsamt LA Kobrak P Jost JJ Clatts MC New injectors and the social context of injection initiation Int J Drug Policy 2008. 18790623
25. Dickenson J Benoit C Budman SH Butler SF Viral spread of prescription opioid administration techniques in Internet chat forums American Pain Society. Tampa, FL 2008.
26. Topp L Day C Degenhardt L Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia Drug Alcohol Depend. 2003, 70(3):275-286. 10.1016/ S0376-8716(03)00013-9 12757965
27. Weatherburn D Jones C Freeman K Makkai T Supply control and harm reduction: Lessons from the Australian heroin 'drought.' Addiction Blackwell Publishing Limited 2003, 98-83. 10.1046/ j.1360-0443.2003.00248.x 12492758
28. Maher L Li J Jalaludin B Wand H Jayasuriya R Dixon D Kaldor JM Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia Drug and Alcohol Dependence 2007, 89:244-250. 10.1016/j.drugalcdep.2007.01.001
29. Dasgupta N Jonsson FM Brownstein JS Comparing unintentional opioid poisoning mortality in metropolitan and non-metropolitan counties, United States, 1999-2003 Geography and Drug Addiction Springer Publishers Richardson TD, Cheung I 2008.
30. Marshall BD Fairbairn N Li K Wood E Kerr T Physical violence among a prospective cohort of injection drug users: A gender-focused approach Drug Alcohol Depend. 2008, 97(3):237-246. 10.1016/ j.drugalcdep.2008.03.028 18487025
31. Havens JR Sherman SG Sapun M Strathdee SA Prevalence and Correlates of Suicidal Ideation Among Young Injection vs. Noninjection Drug Users Substance Use & Misuse 2006, 41:245-254. 10.1080/10826080500391811 16393745
32. Milloy MJ Kerr T Mathias R Zhang R Montaner JS Tyndall M Wood E Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility Am J Drug Alcohol Abuse. 2008, 34(4):499-509. 10.1080/00952990802122457 18584579
33. Sherman SG Cheng Y Kral AH Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city Drug Alcohol Depend. 2007, 88(2-3):182-187. 10.1016/j.drugalcdep.2006.10.006 17110058 1950747
34. Pollini RA McCall L Mehta SH Vlahov D Strathdee SA Non-fatal overdose and subsequent drug treatment among injection drug users Drug and Alcohol Dependence 2006, 83:104-110. 10.1016/j.drugalcdep.2005.10.015
35. Stoové MA Dietze PM Aitken CK Jolley D Mortality among injecting drug users in Melbourne: A 16-year follow-up of the Victorian Injecting Cohort Study (VICS) Drug and Alcohol Dependence 2008, 96:281-285. 10.1016/j.drugalcdep.2008.03.006
36. Vlahov D Wang C Ompad D Fuller CM Caceres W Ouellet L Kerndt P Des Jarlais DC Garfein RS Mortality risk among recent-onset injection drug users in five U.S. Cities Substance Use and Misuse 2008, 43:413-428. 10.1080/10826080701203013
37. Disney E Kidorf M Kolodner K King V Peirce J Beilenson P Brooner RK Psychiatric Comorbidity Is Associated With Drug Use and HIV Risk in Syringe Exchange Participants Journal of Nervous and Mental Disease 2006, 194:577-583. 10.1097/01.nmd.0000230396.17230.28
38. Hall AJ Logan JE Toblin RL Kaplan JA Kraner JC Bixler D Crosby AE Paulozzi LJ Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities JAMA 2008, 300:2613-2620. 10.1001/jama.2008.802 19066381
39. Aceijas C Rhodes T Global estimates of prevalence of HCV infection among injecting drug users International Journal of Drug Policy 2007, 18:352-358. 10.1016/j.drugpo.2007.04.004 17854722
40. Neaigus A Gyarmathy VA Miller M Frajzyngier V Zhao M Friedman SR Des Jarlais DC Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors Drug and Alcohol Dependence 2007, 89:234-243. 10.1016/j.drugalcdep.2007.01.003
41. Backmund M Meyer K Schuetz C Reimer J Factors associated with exposure to hepatitis B virus in injection drug users Drug and Alcohol Dependence 2006, 84:154-159. 10.1016/j.drugalcdep.2006.01.009
42. Lankenau SE Sanders B Jackson Bloom J Hathazi DS Alarcon E Tortu S Clatts M Prevalence and patterns of prescription drug misuse among young ketamine injectors J Drug Issues 2007, 37(3):717-736. 2443940 18612374
43. Gossop M Addiction: Treatment and outcome J R Soc Med 1992, 85:469-472. 1293592 1404196
44. Gossop M Darke S Griffiths P Hando J Powis B Hall W Strang J The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users Addiction 1995, 90:607-614. 10.1111/j.1360-0443.1995.tb02199.x 7795497
45. Strang J Griffiths P Powis B Gossop M Heroin chasers and heroin injectors: Differences observed in a community sample in London, UK Am J Addict 1999, 8:148-160. 10.1080/105504999305956 10365195